Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Cells ; 10(3)2021 03 22.
Article in English | MEDLINE | ID: mdl-33809987

ABSTRACT

Neurodegenerative disorders are desperately lacking treatment options. It is imperative that drug repurposing be considered in the fight against neurodegenerative diseases. Fenamates have been studied for efficacy in treating several neurodegenerative diseases. The purpose of this review is to comprehensively present the past and current research on fenamates in the context of neurodegenerative diseases with a special emphasis on tolfenamic acid and Alzheimer's disease. Furthermore, this review discusses the major molecular pathways modulated by fenamates.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Fenamates/therapeutic use , Nerve Degeneration , Neurodegenerative Diseases/drug therapy , Neurons/drug effects , Neuroprotective Agents/therapeutic use , Animals , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics , Fenamates/adverse effects , Fenamates/pharmacokinetics , Humans , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/pathology , Neurons/metabolism , Neurons/pathology , Neuroprotective Agents/adverse effects , Neuroprotective Agents/pharmacokinetics
SELECTION OF CITATIONS
SEARCH DETAIL
...